Liver‐Selective MMP‐9 Inhibition in the Rat Eliminates Ischemia‐Reperfusion Injury and Accelerates Liver Regeneration
- 20 December 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 69 (1) , 314-328
Abstract
Recruitment of liver sinusoidal endothelial cell progenitor cells (sprocs) from the bone marrow by vascular endothelial growth factor‐stromal cell‐derived factor‐1 (VEGF‐sdf‐1) signaling promotes recovery from injury and drives liver regeneration. Matrix metalloproteinases (MMPs) can proteolytically cleave VEGF, which might inhibit progenitor cell recruitment, but systemic matrix metalloproteinase inhibition might prevent efflux of progenitors from the bone marrow. The hypothesis for this study was that liver‐selective MMP‐9 inhibition would protect the hepatic VEGF‐sdf‐1 signaling pathway, enhance bone marrow sproc recruitment, and thereby ameliorate liver injury and accelerate liver regeneration, whereas systemic MMP inhibition would impair bone marrow sproc mobilization and therefore have less benefit or be detrimental. We found that liver‐selective MMP‐9 inhibition accelerated liver regeneration after partial hepatectomy by 40%, whereas systemic MMP inhibition impaired liver regeneration. Liver‐selective MMP‐9 inhibition largely abolished warm ischemia‐reperfusion injury. In the extended hepatectomy model, liver‐selective MMP‐9 inhibition restored liver sinusoidal endothelial cell integrity, enhanced liver regeneration, and reduced ascites. Liver‐selective MMP‐9 inhibition markedly increased recruitment and engraftment of bone marrow sprocs, whereas systemic MMP inhibition impaired mobilization of bone marrow sprocs and their hepatic engraftment. Hepatic MMP‐9 proteolytically cleaved VEGF after partial hepatectomy. Liver‐selective MMP‐9 inhibition prevented VEGF cleavage and doubled protein expression of VEGF and its downstream signaling partner sdf‐1. In contrast, systemic MMP inhibition enhanced recruitment and engraftment of infused allogeneic progenitors. Conclusion : Liver‐selective MMP inhibition prevents proteolytic cleavage of hepatic VEGF, which enhances recruitment and engraftment of bone marrow sprocs after liver injury. This ameliorates injury and accelerates liver regeneration. Liver‐selective MMP‐9 inhibition may be a therapeutic tool for liver injury that damages the vasculature, whereas systemic MMP inhibition can enhance the benefit of stem cell therapy with endothelial progenitor cells.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK46357)
- Pharmaceuticals
This publication has 51 references indexed in Scilit:
- Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitisAnnals of Thoracic Medicine, 2013
- Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in ratsJournal of Clinical Investigation, 2012
- Acute Treatment with Candesartan Reduces Early Injury After Permanent Middle Cerebral Artery OcclusionTranslational Stroke Research, 2011
- Inductive angiocrine signals from sinusoidal endothelium are required for liver regenerationNature, 2010
- Isolation of periportal, midlobular, and centrilobular rat liver sinusoidal endothelial cells enables study of zonated drug toxicityAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Inhibition of Matrix Metalloproteinase-9 Attenuates Acute Small-for-Size Liver Graft Injury in RatsAmerican Journal of Transplantation, 2010
- Bone Marrow Progenitor Cells Repair Rat Hepatic Sinusoidal Endothelial Cells After Liver InjuryGastroenterology, 2009
- Fibronectin-α4β1 Integrin Interactions Regulate Metalloproteinase-9 Expression in Steatotic Liver Ischemia and Reperfusion InjuryThe American Journal of Pathology, 2007
- Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injuryEuropean Journal of Cardio-Thoracic Surgery, 2002
- Sinusoidal Ultrastructure Evaluated During the Revascularization of Regenerating Rat LiverHepatology, 2001